These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Expression of neurotrophins and their receptors in pigment cell lesions of the skin. Innominato PF, Libbrecht L, van den Oord JJ. J Pathol; 2001 May; 194(1):95-100. PubMed ID: 11329147 [Abstract] [Full Text] [Related]
8. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas. Elder DE, Rodeck U, Thurin J, Cardillo F, Clark WH, Stewart R, Herlyn M. Cancer Res; 1989 Sep 15; 49(18):5091-6. PubMed ID: 2548711 [Abstract] [Full Text] [Related]
10. Decreased expression of both the low-density lipoprotein receptor-related protein/alpha(2)-macroglobulin receptor and its receptor-associated protein in late stages of cutaneous melanocytic tumor progression. de Vries TJ, Verheijen JH, de Bart AC, Weidle UH, Ruiter DJ, van Muijen GN. Cancer Res; 1996 Mar 15; 56(6):1432-9. PubMed ID: 8640836 [Abstract] [Full Text] [Related]
11. Detection of the c-met proto-oncogene product in normal skin and tumours of melanocytic origin. Saitoh K, Takahashi H, Sawada N, Parsons PG. J Pathol; 1994 Nov 15; 174(3):191-9. PubMed ID: 7823252 [Abstract] [Full Text] [Related]
13. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions. Simonetti O, Lucarini G, Brancorsini D, Nita P, Bernardini ML, Biagini G, Offidani A. Cancer; 2002 Nov 01; 95(9):1963-70. PubMed ID: 12404291 [Abstract] [Full Text] [Related]
14. Nerve growth factor receptors on dissociated neurofibroma Schwann-like cells. Sonnenfeld KH, Bernd P, Sobue G, Lebwohl M, Rubenstein AE. Cancer Res; 1986 Mar 01; 46(3):1446-52. PubMed ID: 3002618 [Abstract] [Full Text] [Related]
15. Expression of c-kit (CD117) in Spitz nevus and malignant melanoma. Isabel Zhu Y, Fitzpatrick JE. J Cutan Pathol; 2006 Jan 01; 33(1):33-7. PubMed ID: 16441409 [Abstract] [Full Text] [Related]
16. Divergent cellular differentiation pathways during the invasive stage of cutaneous malignant melanoma progression. Reed JA, Finnerty B, Albino AP. Am J Pathol; 1999 Aug 01; 155(2):549-55. PubMed ID: 10433947 [Abstract] [Full Text] [Related]
17. Molecular analysis of melanoma precursor lesions. Wang Y, Rao U, Mascari R, Richards TJ, Panson AJ, Edington HD, Shipe-Spotloe JM, Donnelly SS, Kirkwood JM, Becker D. Cell Growth Differ; 1996 Dec 01; 7(12):1733-40. PubMed ID: 8959342 [Abstract] [Full Text] [Related]
18. Selective expression of Syntaxin-7 protein in benign melanocytes and malignant melanoma. Strömberg S, Agnarsdóttir M, Magnusson K, Rexhepaj E, Bolander A, Lundberg E, Asplund A, Ryan D, Rafferty M, Gallagher WM, Uhlen M, Bergqvist M, Ponten F. J Proteome Res; 2009 Apr 01; 8(4):1639-46. PubMed ID: 19714869 [Abstract] [Full Text] [Related]
19. Bcl-2 expression in human melanocytes and melanocytic tumors. van den Oord JJ, Vandeghinste N, De Ley M, De Wolf-Peeters C. Am J Pathol; 1994 Aug 01; 145(2):294-300. PubMed ID: 8053490 [Abstract] [Full Text] [Related]
20. Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression. Montone KT, van Belle P, Elenitsas R, Elder DE. Mod Pathol; 1997 Sep 01; 10(9):939-44. PubMed ID: 9310959 [Abstract] [Full Text] [Related] Page: [Next] [New Search]